Contrarian Corpus
activist full deck proxy fight
2018-04-17 · 44 pages

Xerox Corporation XRX

Xerox's CEO is handing 50.1% control to Fuji 'without spending a penny' for ~$28/share; vote down the deal and replace the board to unlock $54-$64 standalone.

N 5 Narrative
V 3 Visual
C 3 Craft
Original source ↗

Thesis

Carl Icahn (9.2%) and Darwin Deason (6%) argue that Xerox's board, led by a conflicted CEO Jeff Jacobson, has negotiated a 'tortured and convoluted' transaction in which Fujifilm acquires a 50.1% controlling stake in Xerox without spending any cash, exploiting a 'crown jewel' lock-up buried in a 17-year-old JV agreement that management concealed from shareholders. Their analysis shows the deal delivers only ~$28 per share — not the $45 management claims — because Fuji Xerox is valued at 7.5x EBITDA versus Xerox at 5.0x, despite Fuji Xerox's lower margins, declining revenue and an unresolved $360M accounting scandal. As an alternative, Icahn and Deason propose a new board, removing Jacobson, and a four-part standalone plan (adjacent services, network/channel cost cuts, IP monetization, Asia-Pacific renegotiation) that they value at $54-$64 per share plus optionality on a true future control premium.

SCQA

Situation

Xerox is an iconic American printing and document-services company whose shares have lagged peers and the S&P 500 over 1, 3 and 5 years, trading at 7.8x P/E versus a 19.3x peer multiple under CEO Jeff Jacobson.

Complication

Management concealed a 17-year-old 'crown jewel' lock-up with Fuji, then used it to justify a no-premium deal handing Fuji 50.1% control 'without spending a penny' — negotiated by a conflicted CEO who 'served as a loyal agent of the acquirer.'

Resolution

Vote AGAINST the Fuji transaction and FOR Icahn and Deason's nominee slate, replace Jacobson and the board, renegotiate or terminate the JV agreements, and execute a four-part standalone value plan.

Reward

Standalone Xerox is worth $54-$64 per share at 6.5x-7.5x EBITDA versus only ~$28 of real value in the proposed deal, plus the optionality of a true control premium in a future sale.

The three reasons

  1. 1

    Fuji acquires 50.1% control of Xerox 'without spending a penny' via convoluted JV recapitalization

  2. 2

    Real transaction value is ~$28/share, not the $45 management touts — a 60% overstatement

  3. 3

    Standalone Xerox plan delivers $54-$64/share with potential for a true control premium later

Primary demands

  • Vote AGAINST the proposed Fuji/Xerox transaction
  • Vote FOR a new slate of directors nominated by Icahn and Deason
  • Replace CEO Jeff Jacobson and Chairman Bob Keegan
  • Renegotiate or terminate the JV 'crown jewel' lock-up with Fuji
  • Run Xerox as a standalone company executing a four-part value plan

KPIs cited

5-year total shareholder return
Xerox 37.2% vs S&P 500 84.0% and peer group 54.5%
3-year total shareholder return
Xerox (10.9%) vs S&P 500 32.6% and peer group 24.5%
Current 2018E P/E
Xerox 7.8x vs peer group 19.3x
Cost cuts vs margin improvement
$1.23B touted in cost cuts but only ~$30M flowed to bottom line over two years
2017 cost creep offset
$680M of 2017 cost savings offset by $556M of opaque 'cost creep'
Adjusted operating margin
12.5% in 2015/2016 to 12.8% in 2017 — only 30 bps of improvement
Implied EBITDA multiple in deal
Xerox at 5.0x 2018E EBITDA vs Fuji Xerox at 7.5x — a 2.5 turn premium for Fuji
Transaction value per share
Board claims $45; Icahn/Deason analysis shows ~$28
Fuji Xerox margin profile
EBITDA 11% / Op Profit 7% vs Xerox 16% / 12%
Net cash flow multiple
Xerox shareholders selling $535M of recurring cash flow for ~$1.25B — only 2.3x
Fuji Xerox accounting scandal
$360M, impacted FY2009-2017, four senior executives 'retired'
Stock price decline since announcement
$28.17 on April 13, 2018 — 14% below pre-announcement and 37% below the $45 deal value

Pattern membership

Where this document fits across the library's 12 rhetorical / structural patterns.

Precedents cited

  • Apple (Icahn — improved capital allocation)
  • eBay (Icahn — PayPal spin-off)
  • Forest Labs (Icahn — sold to Actavis)
  • Motorola (Icahn — split and sold to Google)
  • ImClone (Icahn — sold to Eli Lilly)
  • Kerr McGee (Icahn — sold to Anadarko)
  • Conduent spin-off (Icahn-championed at Xerox)
  • ACS sale to Xerox at $8.7B (Deason)

Notable slides (7)

Notes

Joint Icahn/Deason proxy-fight deck opposing the Fuji/Xerox transaction. Combined disclosed stake ~15.2% (Icahn 9.2% + Deason 6.0%); only Icahn's 9.2% used for stake_disclosed_pct as the lead activist. Strong SCQA structure with Charles Prince private email used as direct CEO/board contradiction (p.11) and CFO William Osbourn quoted on cost creep (p.9). Layout is functional institutional PowerPoint with heavy red highlighting/underlining for emphasis — effective rhetorically but visually unremarkable. Document also signed by Darwin Deason; primary author credited as Icahn given firm prominence and cover.